ANIDULAFUNGIN Side Effects

6984886-2 | Dehydration, Hypotension, Renal Failure Acute
on Sep 08, 2010 Male patient from UNITED STATES , weighting 140.2 lb, was diagnosed with systemic candida and was treated with Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, hypotension, renal failure acute. Anidulafungin dosage: 200 Mg, 1x/day. During the same period patient was treated with FLUCONAZOLE (400 Mg, 1x/day) (View Fluconazole Review and Fluconazole Label ), HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NIFEDIPINE (Unk) (View Nifedipine Review and Nifedipine Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), METHADONE (View Methadone Review and Methadone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ). Patient was hospitalized.

6973612-9 | Dehydration, Hypotension, Renal Failure Acute
Patient was taking Anidulafungin (View Usage). Patient had the following side effects: dehydration, hypotension, renal failure acute on Sep 04, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 140.2 lb, was diagnosed with systemic candida and. Anidulafungin dosage: 200 Mg, 1x/day. During the same period patient was treated with FLUCONAZOLE (400 Mg, 1x/day) (View Fluconazole Review and Fluconazole Label ), HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), METHADONE (View Methadone Review and Methadone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ). Patient was hospitalized.

6933799-0 | Dehydration, Hypotension, Renal Failure Acute
Adverse event was reported on Aug 14, 2010 by a Male patient taking Anidulafungin (View Usage) (Dosage: 100 Mg, 1x/day) was diagnosed with systemic candida and. Location: UNITED STATES , weighting 140.2 lb, After Anidulafungin was administered, patient had the following side effects: dehydration, hypotension, renal failure acute. During the same period patient was treated with FLUCONAZOLE (400 Mg, 1x/day) (View Fluconazole Review and Fluconazole Label ), HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6900482-7 | Bradycardia
on Jul 22, 2010 Female patient from FRANCE , 68 years of age, weighting 143.3 lb, was diagnosed with aspergillosis, hypertension, prophylaxis, pulmonary oedema, pyrexia and was treated with Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia. Anidulafungin dosage: 100 Mg, 1x/day. During the same period patient was treated with VORICONAZOLE (360 Mg, 2x/day) (View Voriconazole Review and Voriconazole Label ), CORGARD (80 Mg, 2x/day) (View Corgard Review and Corgard Label ), FLUCONAZOLE (200 Mg, 2x/day) (View Fluconazole Review and Fluconazole Label ), METHYLPREDNISOLONE (60 Mg, 1x/day) (View Methylprednisolone Review and Methylprednisolone Label ), FUROSEMIDE (100 Mg, 2x/day) (View Furosemide Review and Furosemide Label ), PIPERACILLIN AND TAZOBACTAM (4 G, 3x/day) (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ).


6882006-6 | Bradycardia
on Jul 22, 2010 Female patient from FRANCE , 68 years of age, weighting 143.3 lb, was diagnosed with aspergillosis, hypertension, prophylaxis, pulmonary oedema, pyrexia and was treated with Anidulafungin (View Usage). Patient had the following side effects: bradycardia. Anidulafungin dosage: 130 Ml, 1x/day. During the same period patient was treated with VORICONAZOLE (360 Mg, 2x/day) (View Voriconazole Review and Voriconazole Label ), CORGARD (80 Mg, 2x/day) (View Corgard Review and Corgard Label ), FLUCONAZOLE (200 Mg, 2x/day) (View Fluconazole Review and Fluconazole Label ), METHYLPREDNISOLONE (60 Mg, 1x/day) (View Methylprednisolone Review and Methylprednisolone Label ), FUROSEMIDE (100 Mg, 2x/day) (View Furosemide Review and Furosemide Label ), PIPERACILLIN AND TAZOBACTAM (4 G, 3x/day) (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ).

6817913-3 | Bacterial Test Positive, Catheter Culture Positive, Multi-organ Failure, Pathogen Resistance, Pseudomonas Infection, Septic Shock
Patient was taking Anidulafungin (View Usage). After Anidulafungin was administered, patient had the following side effects: bacterial test positive, catheter culture positive, multi-organ failure, pathogen resistance, pseudomonas infection, septic shock on Jun 24, 2010 from FRANCE Additional patient health information: Male patient , 44 years of age, was diagnosed with systemic candida and. Anidulafungin dosage: 100 Mg, 1x/day. During the same period patient was treated with INIPOMP (Unk) (View Inipomp Review and Inipomp Label ), VENTOLIN (Unk) (View Ventolin Review and Ventolin Label ), DUPHALAC (Unk) (View Duphalac Review and Duphalac Label ), COLIMYCINE (Unk) (View Colimycine Review and Colimycine Label ), AZACTAM (Unk) (View Azactam Review and Azactam Label ), BUMEX (Unk) (View Bumex Review and Bumex Label ), MUCOMYST (Unk) (View Mucomyst Review and Mucomyst Label ), SUFENTA PRESERVATIVE FREE (Unk) (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ).

6817731-6 | Convulsion
Adverse event was reported on Jun 24, 2010 by a Male patient taking Anidulafungin (View Usage) (Dosage: 200 Mg, 1x/day) was diagnosed with systemic candida and. Location: TURKEY , 54 years of age, weighting 160.9 lb, Patient experienced the following unwanted or unexpected effects: convulsion. During the same period patient was treated with PETHIDINE HYDROCHLORIDE (Unk) (View Pethidine Hydrochloride Review and Pethidine Hydrochloride Label ), LORAZEPAM (Unk) (View Lorazepam Review and Lorazepam Label ), FENTANYL (Unk) (View Fentanyl Review and Fentanyl Label ), METRONIDAZOLE (Unk) (View Metronidazole Review and Metronidazole Label ), GRANISETRON (Unk) (View Granisetron Review and Granisetron Label ), FILGRASTIM (Unk) (View Filgrastim Review and Filgrastim Label ), TEICOPLANIN (Unk) (View Teicoplanin Review and Teicoplanin Label ).

6781970-3 | Ileus, Infusion Related Reaction
on Jun 09, 2010 Male patient from SLOVAKIA (Slovak Republic) , 25 years of age, weighting 147.7 lb, was diagnosed with systemic candida and was treated with Anidulafungin (View Usage). Patient had the following side effects: ileus, infusion related reaction. Anidulafungin dosage: 200 Ml, 1x/day. Patient was hospitalized.

6717705-X | Convulsion
on May 07, 2010 Male patient from TURKEY , 54 years of age, weighting 160.9 lb, was diagnosed with systemic candida and was treated with Anidulafungin (View Usage). After Anidulafungin was administered, patient had the following side effects: convulsion. Anidulafungin dosage: 100 Mg, 1x/day. During the same period patient was treated with PETHIDINE HYDROCHLORIDE (Unk) (View Pethidine Hydrochloride Review and Pethidine Hydrochloride Label ), LORAZEPAM (Unk) (View Lorazepam Review and Lorazepam Label ), FENTANYL (Unk) (View Fentanyl Review and Fentanyl Label ), METRONIDAZOLE (Unk) (View Metronidazole Review and Metronidazole Label ), GRANISETRON (Unk) (View Granisetron Review and Granisetron Label ), FILGRASTIM (Unk) (View Filgrastim Review and Filgrastim Label ), TEICOPLANIN (Unk) (View Teicoplanin Review and Teicoplanin Label ), IMIPENEM (Unk) (View Imipenem Review and Imipenem Label ).

6700256-6 | Venoocclusive Liver Disease
Patient was taking Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: venoocclusive liver disease on Apr 16, 2010 from SPAIN Additional patient health information: Male patient , 23 years of age, was diagnosed with systemic candida, aspergillosis, prophylaxis against graft versus host disease and. Anidulafungin dosage: 560 Ml, 1x/day. During the same period patient was treated with VORICONAZOLE (274 Mg, 2x/day) (View Voriconazole Review and Voriconazole Label ), CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6700242-6 | Venoocclusive Liver Disease
Adverse event was reported on Apr 16, 2010 by a Male patient taking Anidulafungin (View Usage) (Dosage: 560 Ml, 1x/day) was diagnosed with systemic candida, aspergillosis, prophylaxis against graft versus host disease and. Location: SPAIN , 23 years of age, Patient had the following side effects: venoocclusive liver disease. During the same period patient was treated with VORICONAZOLE (274 Mg, 2x/day) (View Voriconazole Review and Voriconazole Label ), CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6608847-8 | Ileus, Infusion Related Reaction
on Feb 17, 2010 Male patient from SLOVAKIA (Slovak Republic) , 25 years of age, weighting 147.7 lb, was diagnosed with systemic candida and was treated with Anidulafungin (View Usage). After Anidulafungin was administered, patient had the following side effects: ileus, infusion related reaction. Anidulafungin dosage: 200 Ml, 1x/day. Patient was hospitalized.

6588958-6 | Device Related Infection, Hepatic Failure, Renal Failure, Respiratory Failure
on Feb 09, 2010 Female patient from GERMANY , 66 years of age, weighting 114.6 lb, was diagnosed with aspergillosis and was treated with Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: device related infection, hepatic failure, renal failure, respiratory failure. Anidulafungin dosage: 200 Mg, 1x/day. During the same period patient was treated with VORICONAZOLE (4 Mg/kg, 2x/day) (View Voriconazole Review and Voriconazole Label ), TIGECYCLINE (100 Mg, 1x/day) (View Tigecycline Review and Tigecycline Label ), BETAISODONA (Unk) (View Betaisodona Review and Betaisodona Label ), AMPHOTERICIN B (Unk) (View Amphotericin B Review and Amphotericin B Label ), L THYROXIN (Unk) (View L-thyroxin Review and L-thyroxin Label ), TAVANIC (Unk) (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

6519662-8 | Convulsion
Patient was taking Anidulafungin (View Usage). Patient had the following side effects: convulsion on Dec 17, 2009 from TURKEY Additional patient health information: Male patient , 54 years of age, weighting 160.9 lb, was diagnosed with systemic candida and. Anidulafungin dosage: 100 Mg, 1x/day. During the same period patient was treated with PETHIDINE HYDROCHLORIDE (Unk) (View Pethidine Hydrochloride Review and Pethidine Hydrochloride Label ), LORAZEPAM (Unk) (View Lorazepam Review and Lorazepam Label ), FENTANYL (Unk) (View Fentanyl Review and Fentanyl Label ), METRONIDAZOLE (Unk) (View Metronidazole Review and Metronidazole Label ), GRANISETRON (Unk) (View Granisetron Review and Granisetron Label ), FILGRASTIM (Unk) (View Filgrastim Review and Filgrastim Label ), TEICOPLANIN (Unk) (View Teicoplanin Review and Teicoplanin Label ), IMIPENEM (Unk) (View Imipenem Review and Imipenem Label ).

6490542-X | Device Related Infection, Hepatic Failure, Renal Failure, Respiratory Failure
Adverse event was reported on Dec 01, 2009 by a Female patient taking Anidulafungin (View Usage) (Dosage: 200 Mg, 1x/day) was diagnosed with aspergillosis and. Location: GERMANY , 66 years of age, weighting 114.6 lb, After Anidulafungin was administered, patient had the following side effects: device related infection, hepatic failure, renal failure, respiratory failure. During the same period patient was treated with VORICONAZOLE (4 Mg/kg, 2x/day) (View Voriconazole Review and Voriconazole Label ), TIGECYCLINE (100 Mg, 1x/day) (View Tigecycline Review and Tigecycline Label ), BETAISODONA (Unk) (View Betaisodona Review and Betaisodona Label ), AMPHOTERICIN B (Unk) (View Amphotericin B Review and Amphotericin B Label ), L THYROXIN (Unk) (View L-thyroxin Review and L-thyroxin Label ), TAVANIC (Unk) (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

6406775-4 | Respiratory Failure, Tachycardia, Ventricular Fibrillation
on Oct 08, 2009 Female patient from GERMANY , 69 years of age, was diagnosed with systemic candida, infection prophylaxis and was treated with Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory failure, tachycardia, ventricular fibrillation. Anidulafungin dosage: Unk Mg, 2x/day. During the same period patient was treated with VORICONAZOLE (280 Mg, 2x/day) (View Voriconazole Review and Voriconazole Label ), CIPROFLOXACIN (Unk) (View Ciprofloxacin Review and Ciprofloxacin Label ), DOXYCYCLINE (Unk) (View Doxycycline Review and Doxycycline Label ), AVELOX (View Avelox Review and Avelox Label ), ACICLOVIR (Unk) (View Aciclovir Review and Aciclovir Label ), ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ), ANTITHROMBIN III (Unk) (View Antithrombin Iii Review and Antithrombin Iii Label ). Patient was hospitalized.

6395134-9 | Device Related Infection, Hepatic Failure, Renal Failure, Respiratory Failure
on Sep 28, 2009 Female patient from GERMANY , 66 years of age, was diagnosed with aspergillosis and was treated with Anidulafungin (View Usage). Patient had the following side effects: device related infection, hepatic failure, renal failure, respiratory failure. Anidulafungin dosage: 200 Mg, 1x/day. During the same period patient was treated with VORICONAZOLE (4 Mg/kg, 2x/day) (View Voriconazole Review and Voriconazole Label ), TIGECYCLINE (100 Mg, 1x/day) (View Tigecycline Review and Tigecycline Label ), BETAISODONA (Unk) (View Betaisodona Review and Betaisodona Label ), AMPHOTERICIN B (Unk) (View Amphotericin B Review and Amphotericin B Label ), L THYROXIN (Unk) (View L-thyroxin Review and L-thyroxin Label ), TAVANIC (Unk) (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

6357761-4 | Abscess, Diverticular Perforation, Pulmonary Embolism
Patient was taking Anidulafungin (View Usage). After Anidulafungin was administered, patient had the following side effects: abscess (What is abscess?), diverticular perforation, pulmonary embolism (What is pulmonary embolism?) on Sep 04, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 214.0 lb, was diagnosed with candidiasis and. Anidulafungin dosage: 200 Mg, 1x/day. During the same period patient was treated with NORVASC (Unk) (View Norvasc Review and Norvasc Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), MORPHINE (Unk) (View Morphine Review and Morphine Label ), ZOFRAN (Unk) (View Zofran Review and Zofran Label ), NOVOLIN R (Unk) (View Novolin R Review and Novolin R Label ), PROTONIX (Unk) (View Protonix Review and Protonix Label ), METRONIDAZOLE (Unk) (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

6349581-1 | Catheter Related Infection, Hepatic Failure, Renal Failure, Respiratory Failure
Adverse event was reported on Aug 31, 2009 by a Female patient taking Anidulafungin (View Usage) (Dosage: 200 Mg, 1x/day) was diagnosed with aspergillosis and. Location: GERMANY , 66 years of age, Patient experienced the following unwanted or unexpected effects: catheter related infection, hepatic failure, renal failure, respiratory failure. During the same period patient was treated with VORICONAZOLE (4 Mg/kg, 2x/day) (View Voriconazole Review and Voriconazole Label ), TIGECYCLINE (100 Mg, 1x/day) (View Tigecycline Review and Tigecycline Label ), BETAISODONA (Unk) (View Betaisodona Review and Betaisodona Label ), AMPHOTERICIN B (Unk) (View Amphotericin B Review and Amphotericin B Label ), L THYROXIN (Unk) (View L-thyroxin Review and L-thyroxin Label ), TAVANIC (Unk) (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

6343583-7 | Venoocclusive Liver Disease
on Aug 27, 2009 Female patient from SPAIN , 23 years of age, was diagnosed with systemic candida, aspergillosis, prophylaxis against graft versus host disease and was treated with Anidulafungin (View Usage). Patient had the following side effects: venoocclusive liver disease. Anidulafungin dosage: 560 Ml, 1x/day. During the same period patient was treated with VORICONAZOLE (274 Mg, 2x/day) (View Voriconazole Review and Voriconazole Label ), CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6340923-X | Catheter Related Infection, Hepatic Failure, Renal Failure, Respiratory Failure
on Aug 31, 2009 Female patient from GERMANY , 66 years of age, was diagnosed with aspergillosis and was treated with Anidulafungin (View Usage). After Anidulafungin was administered, patient had the following side effects: catheter related infection, hepatic failure, renal failure, respiratory failure. Anidulafungin dosage: 200 Mg, 1x/day. During the same period patient was treated with VORICONAZOLE (4 Mg/kg, 2x/day) (View Voriconazole Review and Voriconazole Label ), TIGECYCLINE (100 Mg, 1x/day) (View Tigecycline Review and Tigecycline Label ), BETAISODONA (Unk) (View Betaisodona Review and Betaisodona Label ), AMPHOTERICIN B (Unk) (View Amphotericin B Review and Amphotericin B Label ), L THYROXIN (Unk) (View L-thyroxin Review and L-thyroxin Label ), TAVANIC (Unk) (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

6305076-2 | Respiratory Failure, Tachycardia, Ventricular Fibrillation
Patient was taking Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory failure, tachycardia, ventricular fibrillation on Jul 30, 2009 from GERMANY Additional patient health information: Female patient , 69 years of age, was diagnosed with systemic candida, infection prophylaxis and. Anidulafungin dosage: Unk Mg, 2x/day. During the same period patient was treated with VORICONAZOLE (280 Mg, 2x/day) (View Voriconazole Review and Voriconazole Label ), CIPROFLOXACIN (Unk) (View Ciprofloxacin Review and Ciprofloxacin Label ), DOXYCYCLINE (Unk) (View Doxycycline Review and Doxycycline Label ), AVELOX (View Avelox Review and Avelox Label ), ACICLOVIR (Unk) (View Aciclovir Review and Aciclovir Label ), ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ), ANTITHROMBIN III (Unk) (View Antithrombin Iii Review and Antithrombin Iii Label ). Patient was hospitalized.

6296559-2 | Respiratory Failure, Tachycardia, Ventricular Fibrillation
Adverse event was reported on Jul 30, 2009 by a Female patient taking Anidulafungin (View Usage) (Dosage: Unk Mg, 2x/day) was diagnosed with systemic candida, infection prophylaxis and. Location: GERMANY , 69 years of age, Patient had the following side effects: respiratory failure, tachycardia, ventricular fibrillation. During the same period patient was treated with VORICONAZOLE (280 Mg, 2x/day) (View Voriconazole Review and Voriconazole Label ), CIPROFLOXACIN (Unk) (View Ciprofloxacin Review and Ciprofloxacin Label ), DOXYCYCLINE (Unk) (View Doxycycline Review and Doxycycline Label ), AVELOX (View Avelox Review and Avelox Label ), ACICLOVIR (Unk) (View Aciclovir Review and Aciclovir Label ), ALDACTONE (Unk) (View Aldactone Review and Aldactone Label ), ANTITHROMBIN III (Unk) (View Antithrombin Iii Review and Antithrombin Iii Label ). Patient was hospitalized.

6296226-5 | Venoocclusive Liver Disease
on Jul 23, 2009 Female patient from SPAIN , 23 years of age, was diagnosed with systemic candida, aspergillosis, prophylaxis against graft versus host disease and was treated with Anidulafungin (View Usage). After Anidulafungin was administered, patient had the following side effects: venoocclusive liver disease. Anidulafungin dosage: 560 Ml, 1x/day. During the same period patient was treated with VORICONAZOLE (274 Mg, 2x/day) (View Voriconazole Review and Voriconazole Label ), CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6243002-5 | Venoocclusive Liver Disease
on Jun 12, 2009 Female patient from SPAIN , 23 years of age, was diagnosed with systemic candida, aspergillosis, prophylaxis against graft versus host disease and was treated with Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: venoocclusive liver disease. Anidulafungin dosage: 560 Ml, 1x/day. During the same period patient was treated with VORICONAZOLE (274 Mg, 2x/day) (View Voriconazole Review and Voriconazole Label ), CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

6232688-7 | Hyperkalaemia, Septic Shock
Patient was taking Anidulafungin (View Usage). Patient had the following side effects: hyperkalaemia, septic shock on Jun 05, 2009 from MEXICO Additional patient health information: Female patient , 77 years of age, was diagnosed with systemic candida and. Anidulafungin dosage: 200 Mg, 1x/day, Every. During the same period patient was treated with LEVOTHYROXINE SODIUM (Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), METRONIDAZOLE (Unk) (View Metronidazole Review and Metronidazole Label ), TRAMADOL HYDROCHLORIDE (Unk) (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ), LOPERAMIDE HYDROCHLORIDE (Unk) (View Loperamide Hydrochloride Review and Loperamide Hydrochloride Label ), PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM (View Piperacillin Sodium And Tazobactam Sodium Review and Piperacillin Sodium And Tazobactam Sodium Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6215122-2 | Abscess, Diverticular Perforation, Pulmonary Embolism
Adverse event was reported on Apr 15, 2009 by a Female patient taking Anidulafungin (View Usage) (Dosage: 200 Mg, 1x/day) was diagnosed with candidiasis and. Location: UNITED STATES , weighting 214.0 lb, After Anidulafungin was administered, patient had the following side effects: abscess (What is abscess?), diverticular perforation, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with NORVASC (Unk) (View Norvasc Review and Norvasc Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), MORPHINE (Unk) (View Morphine Review and Morphine Label ), ZOFRAN (Unk) (View Zofran Review and Zofran Label ), NOVOLIN R (Unk) (View Novolin R Review and Novolin R Label ), PROTONIX (Unk) (View Protonix Review and Protonix Label ), METRONIDAZOLE (Unk) (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

6209038-5 | Pneumonia, Pyrexia
on May 14, 2009 Female patient from BRAZIL , 56 years of age, was diagnosed with systemic candida and was treated with Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), pyrexia. Anidulafungin dosage: 100 Mg, 1x/day. During the same period patient was treated with SOLU CORTEF (Unk) (View Solu-cortef Review and Solu-cortef Label ), TERBUTALINE SULFATE (Unk) (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), SULFADIAZINE (Unk) (View Sulfadiazine Review and Sulfadiazine Label ), DERMADEX (Unk) (View Dermadex Review and Dermadex Label ), DIAZEPAM (Unk) (View Diazepam Review and Diazepam Label ), FUROSEMIDE (Unk) (View Furosemide Review and Furosemide Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6208565-4 | Septic Shock
on May 19, 2009 Female patient from FRANCE , 44 years of age, was diagnosed with systemic candida and was treated with Anidulafungin (View Usage). Patient had the following side effects: septic shock. Anidulafungin dosage: 100 Mg, 1x/day. During the same period patient was treated with INIPOMP (Unk) (View Inipomp Review and Inipomp Label ), VENTOLIN (Unk) (View Ventolin Review and Ventolin Label ), DUPHALAC (Unk) (View Duphalac Review and Duphalac Label ), COLIMYCINE (Unk) (View Colimycine Review and Colimycine Label ), AZACTAM (Unk) (View Azactam Review and Azactam Label ), BUMEX (Unk) (View Bumex Review and Bumex Label ), MUCOMYST (Unk) (View Mucomyst Review and Mucomyst Label ), SUFENTA PRESERVATIVE FREE (Unk) (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ). Patient was hospitalized.

6208487-9 | Respiratory Failure
Patient was taking Anidulafungin (View Usage). After Anidulafungin was administered, patient had the following side effects: respiratory failure on Apr 22, 2009 from TAIWAN, PROVINCE OF CHINA Additional patient health information: Female patient , 73 years of age, was diagnosed with systemic candida and. Anidulafungin dosage: 100 Mg, 1x/day. During the same period patient was treated with ISONIAZID (100 Mg, Unk) (View Isoniazid Review and Isoniazid Label ), RIFAMPIN (150 Mg, Unk) (View Rifampin Review and Rifampin Label ), ETHAMBUTOL DIHYDROCHLORIDE (400 Mg, Unk) (View Ethambutol Dihydrochloride Review and Ethambutol Dihydrochloride Label ), PYRAZINAMIDE (500 Mg, Unk) (View Pyrazinamide Review and Pyrazinamide Label ), PYRIDOXINE HYDROCHLORIDE (View Pyridoxine Hydrochloride Review and Pyridoxine Hydrochloride Label ), INVANZ (View Invanz Review and Invanz Label ), POTASSIUM CHLORIDE (Unk) (View Potassium Chloride Review and Potassium Chloride Label ), HUMULIN R (Unk) (View Humulin R Review and Humulin R Label ).

6202672-8 | Pseudomembranous Colitis
Adverse event was reported on Apr 20, 2009 by a Male patient taking Anidulafungin (View Usage) (Dosage: 200 Mg, 1x/day) was diagnosed with fungal peritonitis and. Location: UNITED STATES , weighting 110.0 lb, Patient experienced the following unwanted or unexpected effects: pseudomembranous colitis. During the same period patient was treated with FAMOTIDINE (Unk) (View Famotidine Review and Famotidine Label ), HEPARIN (Unk) (View Heparin Review and Heparin Label ), VANCOMYCIN (Unk) (View Vancomycin Review and Vancomycin Label ), FLUCONAZOLE (1 Dose Po, 1 Dose Iv) (View Fluconazole Review and Fluconazole Label ), MICAFUNGIN SODIUM (Unk) (View Micafungin Sodium Review and Micafungin Sodium Label ), INSULIN GLARGINE (Unk) (View Insulin Glargine Review and Insulin Glargine Label ). Patient was hospitalized.

6199466-9 | Septic Shock
on May 19, 2009 Female patient from FRANCE , 44 years of age, was diagnosed with systemic candida and was treated with Anidulafungin (View Usage). Patient had the following side effects: septic shock. Anidulafungin dosage: 100 Mg, 1x/day. During the same period patient was treated with INIPOMP (Unk) (View Inipomp Review and Inipomp Label ), VENTOLIN (Unk) (View Ventolin Review and Ventolin Label ), DUPHALAC (Unk) (View Duphalac Review and Duphalac Label ), COLIMYCINE (Unk) (View Colimycine Review and Colimycine Label ), AZACTAM (Unk) (View Azactam Review and Azactam Label ), BUMEX (Unk) (View Bumex Review and Bumex Label ), MUCOMYST (Unk) (View Mucomyst Review and Mucomyst Label ), SUFENTA PRESERVATIVE FREE (Unk) (View Sufenta Preservative Free Review and Sufenta Preservative Free Label ). Patient was hospitalized.

6104099-6 | Abscess, Diverticular Perforation, Pulmonary Embolism
on Feb 03, 2009 Female patient from UNITED STATES , weighting 214.0 lb, was diagnosed with candidiasis and was treated with Anidulafungin (View Usage). After Anidulafungin was administered, patient had the following side effects: abscess (What is abscess?), diverticular perforation, pulmonary embolism (What is pulmonary embolism?). Anidulafungin dosage: 200 Mg, 1x/day. During the same period patient was treated with NORVASC (Unk) (View Norvasc Review and Norvasc Label ), FOLIC ACID (Unk) (View Folic Acid Review and Folic Acid Label ), MORPHINE (Unk) (View Morphine Review and Morphine Label ), ZOFRAN (Unk) (View Zofran Review and Zofran Label ), NOVOLIN R (Unk) (View Novolin R Review and Novolin R Label ), PROTONIX (Unk) (View Protonix Review and Protonix Label ), METRONIDAZOLE (Unk) (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.

6045405-0 | Localised Intraabdominal Fluid Collection
Patient was taking Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: localised intraabdominal fluid collection on Jan 15, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 156.0 lb, was diagnosed with infection (What is infection?) and. Anidulafungin dosage: 100 Mg, 2x/day. During the same period patient was treated with FLUCONAZOLE (Qday) (View Fluconazole Review and Fluconazole Label ), HEPARIN (Unk) (View Heparin Review and Heparin Label ), DILAUDID (Unk) (View Dilaudid Review and Dilaudid Label ), HYDROCORTISONE (Unk) (View Hydrocortisone Review and Hydrocortisone Label ), MAGNESIUM SULFATE (Unk) (View Magnesium Sulfate Review and Magnesium Sulfate Label ), ZOSYN (Unk) (View Zosyn Review and Zosyn Label ), TORADOL (Unk) (View Toradol Review and Toradol Label ). Patient was hospitalized.

6036180-4 | Abscess, Diverticular Perforation, Pulmonary Embolism
Adverse event was reported on Dec 11, 2008 by a Female patient taking Anidulafungin (View Usage) (Dosage: Unk) was diagnosed with candidiasis and. Location: UNITED STATES , weighting 214.0 lb, Patient had the following side effects: abscess (What is abscess?), diverticular perforation, pulmonary embolism (What is pulmonary embolism?).

5713379-5 | Acute Pulmonary Oedema, Peripheral Ischaemia, Supraventricular Tachycardia
on Apr 11, 2008 Female patient from MEXICO , weighting 149.9 lb, was diagnosed with systemic candida and was treated with Anidulafungin (View Usage). After Anidulafungin was administered, patient had the following side effects: acute pulmonary oedema, peripheral ischaemia, supraventricular tachycardia. Anidulafungin dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), DIPHENYLHYDANTOIN (View Diphenylhydantoin Review and Diphenylhydantoin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), COMBIVENT (View Combivent Review and Combivent Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

5707598-1 | Supraventricular Tachycardia
on Apr 11, 2008 Female patient from MEXICO , weighting 148.8 lb, was treated with Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: supraventricular tachycardia. Anidulafungin dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), DIPHENYLHYDANTOIN (View Diphenylhydantoin Review and Diphenylhydantoin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), COMBIVENT (View Combivent Review and Combivent Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

5706104-5 | Ventricular Tachycardia
Patient was taking Anidulafungin (View Usage). Patient had the following side effects: ventricular tachycardia on Apr 04, 2008 from MEXICO Additional patient health information: Female patient , weighting 148.8 lb, . Anidulafungin dosage: . During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), DIPHENYLHYDANTOIN (View Diphenylhydantoin Review and Diphenylhydantoin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), COMBIVENT (View Combivent Review and Combivent Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

5685377-1 | Ventricular Tachycardia
Adverse event was reported on Mar 18, 2008 by a Female patient taking Anidulafungin (View Usage) (Dosage: ) . Location: MEXICO , 25 years of age, weighting 148.8 lb, After Anidulafungin was administered, patient had the following side effects: ventricular tachycardia. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), KETOROLAC (View Ketorolac Review and Ketorolac Label ), COMBIVENT (View Combivent Review and Combivent Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

5632611-X | Blood Creatine Phosphokinase Increased, Myoglobin Blood Increased, Rhabdomyolysis
on Feb 08, 2008 Male patient from AUSTRIA , weighting 220.5 lb, was diagnosed with candidiasis, hyperlipidaemia and was treated with Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, myoglobin blood increased, rhabdomyolysis. Anidulafungin dosage: Daily Dose:100mg. During the same period patient was treated with SORTIS (Daily Dose:80mg) (View Sortis Review and Sortis Label ), OPTINEM (View Optinem Review and Optinem Label ). Patient was hospitalized.

5626733-7 | Brain Injury
on Feb 04, 2008 Female patient from NETHERLANDS , child 12 years of age, was diagnosed with cerebral aspergillosis and was treated with Anidulafungin (View Usage). Patient had the following side effects: brain injury. Anidulafungin dosage: . During the same period patient was treated with AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ).

5486137-7 | Bronchopulmonary Aspergillosis
Patient was taking Anidulafungin (View Usage). After Anidulafungin was administered, patient had the following side effects: bronchopulmonary aspergillosis on Oct 03, 2007 from UNITED STATES Additional patient health information: Male patient , 69 years of age, . Anidulafungin dosage: .

5486071-2 | Bronchopulmonary Aspergillosis
Adverse event was reported on Oct 03, 2007 by a Female patient taking Anidulafungin (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: UNITED STATES , 60 years of age, Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis.

5454969-7 | Pancreatitis
on Sep 05, 2007 Female patient from , weighting 31.09 lb, was diagnosed with antifungal prophylaxis and was treated with Anidulafungin (View Usage). Patient had the following side effects: pancreatitis. Anidulafungin dosage: Daily Dose:50mg. During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PENICILLIN VK (View Penicillin Vk Review and Penicillin Vk Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

5433631-0 | Rash, Thrombocytopenia
on Aug 28, 2007 Male patient from UNITED STATES , 74 years of age, was diagnosed with fungaemia and was treated with Anidulafungin (View Usage). After Anidulafungin was administered, patient had the following side effects: rash (What is rash?), thrombocytopenia. Anidulafungin dosage: Mg Every Day Iv. Patient was hospitalized.

5376721-3 | Incorrect Dose Administered, Pancreatitis
Patient was taking Anidulafungin (View Usage). Patient experienced the following unwanted or unexpected effects: incorrect dose administered, pancreatitis on Jun 29, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 31.09 lb, was diagnosed with antifungal prophylaxis and. Anidulafungin dosage: 50 Mg Daily Iv. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), PREDNISOLONE/PREDNISONE (View Prednisolone/prednisone Review and Prednisolone/prednisone Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), PENICILLIN VK (View Penicillin Vk Review and Penicillin Vk Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), ANTITHYMOCYTE IMMUNOGLOBULIN RABBIT (View Antithymocyte Immunoglobulin -rabbit- Review and Antithymocyte Immunoglobulin -rabbit- Label ).